Abstract
Non-Pharmaceutical Interventions (NPI) are currently the only mechanism governments can use to mitigate the impact of the COVID-19 epidemic. Similarly to the actual spread of the disease, the dynamics of the contention patterns emerging from the application of NPIs are complex and depend on interactions between people within a specific region as well as other stochastic factors associated to demographic, geographic, political and economical conditions. Agent-based models simulate microscopic rules of simultaneous spatial interactions between multiple agents within a population, in an attempt to reproduce the complex dynamics of the effect of the contention measures. In this way, it is possible to design individual behaviours along with NPI scenarios, measuring how the simulation dynamics is affected and therefore, yielding rapid insights to perform a broad assessment of the potential of composite interventions at different stages of the epidemic. In this paper we describe a model and a tool to experiment with such kind of analysis applied to a conceptual city, considering a number of widely-applied NPIs such as social distancing, case isolation, home quarantine, total lockdown, sentinel testing, mask wearing and a distinctive "zonal" enforcement measure, requiring these interventions to be applied gradually to separated enclosed districts (zones). We find that the model is able to capture emerging dynamics associated to these NPIs; besides, the zonal contention strategy yields an improvement on the mitigation impact across all scenarios of combination with individual NPIs. The model and tool are open to extensions to account for omitted or newer factors affecting the planning and design of NPIs intended to counter the late stages or forthcoming waves of the COVID-19 crisis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB and/or ethics committee was not necessary.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Experiment data is available upon request. The software is publicly available at http://modelingcommons.org/browse/one_model/6374
